Skip to content

APOTHEEK VANDERSTRAETEN

Active
Private limited companyfounded 1984active for 41 yearsDendermondsesteenweg 268, 9040 Gent, BelgiumKBO/BCE: BE 0426.528.497

From the official registers: KBO 41 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

APOTHEEK VANDERSTRAETEN has been active since 1984 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €420,708 and a net result of -€1,932. Equity is growing by about 3.6% per year across the filed financial years. Its solvency ranks better than 37% of 12,757 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.7% (low).

Overview

Official details

KBO
Status
Active since 18-12-1984 Normal situation
Legal form
Private limited company
Registered office
Dendermondsesteenweg 268, 9040 Gent
Activity
Retail sale of pharmaceutical products NACE 47730
Establishment units
2.026.036.921 9040 Gent, since 01-01-1985
2.324.524.628 9940 Evergem, since 01-10-2021
Financial year end
31 December
Peppol
Reachable since 27-12-2025

Who decides

Board
  • BODEPODirector · permanent representative Kathleen Depoorter

How it is doing

68 Healthy Checked score 2025
Bankruptcy probabilitywithin 12 months
0.7%
Annual accounts 2025
Gross margin
€250,208
▼ 12.8%
Turnover
≈ €910,000
estimated
Loss
€1,932
Equity
€420,708
▼ 0.5%
Total assets
€1.7m
▲ 3.2%
Staff
3 FTE
▲ 11.1%
2025 accounts filed 31 days late
Filed on 31-08-2026at the National Bank
Why 68raises riskLast filed accounts filed 31 days late; 2 of the last 3 lateSector: Retail trade (NACE 47)lowers riskFounded in 1984Size: 3 FTE, total assets €1.7mShow the evidence

Checked score

Score 2025
68 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially better than 32% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Weak
Solvency 50-1
equity 25.4% of total assets
Liquidity 28-2
short-term debt 47.8% · cash 1.2%
Profitability 25-15
return on assets -0.1%
Bankruptcy probability, 12 months
0.7% Low
0%0.5%1.5%4%10%≥ 25%

About 7 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,270 companies, NACE 47, micro)
Last 24 months 11-2024: 0.7% 12-2024: 0.7%● unchanged vs 11-2024 01-2025: 0.7%● unchanged vs 12-2024 02-2025: 0.7%● unchanged vs 01-2025 03-2025: 0.7%● unchanged vs 02-2025 04-2025: 0.7%● unchanged vs 03-2025 05-2025: 0.7%● unchanged vs 04-2025 06-2025: 0.7%● unchanged vs 05-2025 07-2025: 0.9%▲ +0.2 percentage points vs 06-2025 08-2025: 1.4%▲ +0.5 percentage points vs 07-2025highest value 09-2025: 0.5%▼ -0.9 percentage points vs 08-2025 10-2025: 0.5%● unchanged vs 09-2025 11-2025: 0.5%● unchanged vs 10-2025 12-2025: 0.5%● unchanged vs 11-2025 01-2026: 0.5%● unchanged vs 12-2025lowest value 02-2026: 0.5%● unchanged vs 01-2026 03-2026: 0.5%● unchanged vs 02-2026 04-2026: 0.5%● unchanged vs 03-2026 05-2026: 0.5%● unchanged vs 04-2026 06-2026: 0.5%● unchanged vs 05-2026 07-2026: 0.5%● unchanged vs 06-2026 08-2026: 1.1%▲ +0.6 percentage points vs 07-2026 09-2026: 0.7%▼ -0.4 percentage points vs 08-2026 10-2026: 0.7%● unchanged vs 09-2026
Credit of up to €25,000 on 30-day terms is acceptable
Liquidity tight (current ratio 1.22, compared with 1.26 in 2024, below the usual 1.5; short-term debt: 47.8% and cash: 1.2% of total assets), and 74.6% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 41% on solvency, 25% on liquidity, 23% on profitability and 37% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises risk
lowers risk · Founded in 1984
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Size: 3 FTE, total assets €1.7m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Last filed accounts filed 31 days late; 2 of the last 3 late
NBB · filings
raises risk · Sector: Retail trade (NACE 47)
KBO
raises risk · 2025 accounts filed 31 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
31 days late
2024
26 days late
2023
49 days late
2022
22 days late
2021
11 days early
2020
12 days late
2019
2 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 18 days after the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 26 August (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage

Documents

Annual accounts at the NBB

All 41 annual accounts

Articles and registers

Key facts about APOTHEEK VANDERSTRAETEN

What is the company number of APOTHEEK VANDERSTRAETEN?
0426.528.497. In Belgium the VAT number is the company number with BE in front: BE 0426.528.497.
Where is APOTHEEK VANDERSTRAETEN based?
The registered office is at Dendermondsesteenweg 268, 9040 Gent.Company details
What does APOTHEEK VANDERSTRAETEN do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK VANDERSTRAETEN?
Private limited company (BV).
When was APOTHEEK VANDERSTRAETEN founded?
On 18-12-1984.
Is APOTHEEK VANDERSTRAETEN still active?
Yes, APOTHEEK VANDERSTRAETEN is an active enterprise in the KBO register.
How many employees does APOTHEEK VANDERSTRAETEN have?
On average 3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of APOTHEEK VANDERSTRAETEN?
≈ €910,000 in financial year 2025. Estimated from the gross margin of €250,208: probably between €710,000 and €1.5m, based on 47 comparable companies, NACE 477.
Is APOTHEEK VANDERSTRAETEN profitable?
In financial year 2025, APOTHEEK VANDERSTRAETEN made a loss of €1,932.
Where can I find the annual accounts of APOTHEEK VANDERSTRAETEN?
APOTHEEK VANDERSTRAETEN filed 41 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of APOTHEEK VANDERSTRAETEN due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to APOTHEEK VANDERSTRAETEN

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.